$ELVR

Uranium prices hit new highs, with long-term contracts at $96.50/lb and spot at $89.63/lb, according to Cameco. Despite this, uranium equities like Cameco (CCJ) and the VanEck Uranium ETF (NLR) have declined. Policy support for nuclear energy grew, with a U.S.-Korea framework for reactor deployment. Lithium prices also rose, with Chinese battery-grade lithium carbonate averaging 122,350 yuan/tonne.

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) signed a 3-year spodumene supply deal with LG Energy Solution, starting in 2026. The agreement covers 240,000 dmt, with optional volumes up to 90,000 dmt. Pricing is market-linked. Elevra aims to diversify its sales portfolio and secure strategic customers for its North American Lithium operations.

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) updates on the sale of its Ewoyaa Lithium Project to Zhejiang Huayou Cobalt. The deal, valued at ~$71M, awaits Ghanaian government approval. If not secured by Oct 30, 2026, Huayou can pay a $5M break fee or terminate. Huayou also received FIRB approval for its acquisition of Atlantic Lithium, which holds the remaining private-sector interest in Ewoyaa.

Elevra Lithium (ASX: ELV, Nasdaq: ELVR) has begun a $366M expansion of its North American Lithium mine in Quebec, aiming to nearly double production to 373,000 tonnes of spodumene concentrate by 2029. The project, funded by equity and convertible notes, is expected to reduce costs and secure customers through price-protected offtake agreements, including a deal with Mangrove Lithium.

Atlantic Lithium (ASX:A11) operates in West Africa and is listed on AIM, OTC. Elevra Lithium (ASX:ELV, NASDAQ:ELVR) updates on selling its Ewoyaa Lithium Project stake to Zhejiang Huayou Cobalt, pending Ghanaian government approval. Huayou has received FIRB approval for acquiring Atlantic Lithium.

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion, targeting increased spodumene production and reduced costs. The project, fully funded at C$366M, aims to boost annual output to 373ktpa by mid-2029, with a post-tax NPV of C$3.218B. The expansion is expected to reduce LOM C1 costs to C$851/t post-expansion, according to the company.

Elevra Lithium reported cash of $255M at June 30, up from $47M a year earlier, with additional funding from convertible notes. NAL produced 198,000 tonnes of spodumene concentrate, down 3% YoY. Expansion plans include increasing milling capacity to 6,500 tonnes per day, with stage one expected by mid-2027. Fiscal 2027 guidance includes production of 198,000-210,000 tonnes and unit costs of $880-$950 per tonne.

Elevra Lithium (ASX:ELV) reported FY26 results, with revenue up 39% to US$202M. NAL mined 1.47M wmt of ore, producing 197,967 dmt of spodumene concentrate. Unit costs rose 2% to US$853/dmt. The company announced a 15-20% production capacity increase from mid-2027, funded by a US$202M equity raise. Cash balance increased to US$255M.

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) signed a binding 7-year spodumene supply deal with Mangrove Lithium, extendable for another 7 years. The agreement covers 122,000 tonnes annually, with a floor price above Elevra's production costs and no ceiling. Both companies are backed by the Canada Growth Fund, aiming to strengthen Canada's lithium supply chain. Mangrove must reach a final investment decision by 2028.